News

The Following Awards were made to Ordway Researchers July 2009 to Present

Cancer Center

Since July 2009, the Cancer Center has been awarded 1 industry contract. In addition, they have received the following Federal and Foundation Awards.

Dr. Ralph Buttyan
DOD Prostate Cancer - Chemical Suppression of the Reactivated Androgen Signaling Pathway in Androgen-Independent Prostate Cancer

Dr. Mengqian Chen and Dr. Ralph Buttyan
DOD Prostate Cancer - Activation of Hh Signaling: A Critical Biological Consequence of ETS Gene Anomalies in Prostate Cancer

Dr. Michael Fasullo
NIH R21 Student Supplement - Activating liver carcinogens in yeast by expressing CYP450 polymorphisms

NIH R21 Administrative Supplement - Activating liver carcinogens in yeast by expressing CYP450 polymorphisms

Dr. Igor Roninson
NIH R01 - Secretory Patterns of Senescent Tumor Cells Year 3

Dr. Stewart Sell
NIH R01 - Stem Cells and Hepatocarcinogenesis Year 5

Center for Biodefense and Emerging Infections

Researchers in the Center for Biodefense and Emerging Infections have been awarded 10 industry contracts since July 2009. In addition, they have received the following Federal and Foundation Awards.

Dr. Jurgen Bulitta
Research Foundation of SUNY – Targeting MDR hetero-resistant Gram-negatives: PK/PD for rational combinations

Drs. George Drusano and James McSharry
NIH R01 Influenza Supplement - Resistance Suppression for Influenza Virus with Combination Chemotherapy

Institute for Clinical Pharmacodynamics (ICPD)

ICPD serves as a center for translational science collaboration. They help pharmaceutical and biotechnology companies get safer and more effective drugs to patients through advanced methods of pharmacokinetic and pharmacodynamic system analysis.

Since July 2009, ICPD has been awarded 15 Industry contracts.